AnalystsCorinne JohnsonCorinne Johnson's Stock Forecasts
AnalystsCorinne Johnson
Sectors:
Analyst Ranking
Top 29%
#1486 out of 5256 analysts
Average Return
+19.22%
Win Rate
40%6 out of 15
Risk vs Reward
Poor
Good
Corinne Johnson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Syndax Pharmaceuticals IncSNDX | +142.16% | $9.82 | $23.78 | 2025-07-09 - 2026-04-20 | Strong Buy |
Amylyx Pharmaceuticals IncAMLX | +137.75% | $7.39 | $17.57 | 2025-07-09 - 2026-04-20 | Strong Buy |
Amylyx Pharmaceuticals IncAMLX | +46.91% | $11.96 | $17.57 | 2025-09-15 - 2026-04-20 | Strong Buy |
Arrivent Biopharma IncAVBP | +42.49% | $22.03 | $31.39 | 2025-07-09 - 2026-04-20 | Strong Buy |
Syndax Pharmaceuticals IncSNDX | +39.55% | $17.04 | $23.78 | 2025-09-04 - 2026-04-20 | Strong Buy |
Corinne Johnson Analyst Color
Get additional color on Corinne Johnson's coverage of popular stocks
Corinne Johnson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Immunovant IncIMVT | 3 | Hold | $32.00 | +12.16% | Maintains | 6 days ago |
Syndax Pharmaceuticals IncSNDX | 3 | Strong Buy | $34.00 | +42.98% | Maintains | 20 days ago |
Tg Therapeutics IncTGTX | 1 | Hold | $39.00 | +5.52% | Maintains | 3 months ago |
Mbx Biosciences IncMBX | 1 | Strong Sell | $18.00 | -46.71% | Initiates Coverage On | 5 months ago |
Amylyx Pharmaceuticals IncAMLX | 2 | Strong Buy | $20.00 | +13.83% | Maintains | 7 months ago |
Avidity Biosciences IncRNAM | 2 | Strong Buy | $55.00 | +272.88% | Reinstates | 9 months ago |
Arrivent Biopharma IncAVBP | 3 | Strong Buy | $33.00 | +5.13% | Reinstates | 9 months ago |
Neurocrine Biosciences IncNBIX | 1 | Strong Buy | $182.00 | +38.31% | Initiates Coverage On | 9 months ago |
Cg Oncology IncCGON | 3 | Strong Buy | $50.00 | N/A | Upgrades | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.